Skip to main content

Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization.

Publication ,  Journal Article
Chakrabarti, BK; Kong, W-P; Wu, B-Y; Yang, Z-Y; Friborg, J; Ling, X; King, SR; Montefiori, DC; Nabel, GJ
Published in: J Virol
June 2002

In this study, we have investigated the effect of specific mutations in human immunodeficiency virus type 1 (HIV-1) envelope (Env) on antibody production in an effort to improve humoral immune responses to this glycoprotein by DNA vaccination. Mice were injected with plasmid expression vectors encoding HIV Env with modifications in regions that might affect this response. Elimination of conserved glycosylation sites did not substantially enhance humoral or cytotoxic-T-lymphocyte (CTL) immunity. In contrast, a modified gp140 with different COOH-terminal mutations intended to mimic a fusion intermediate and stabilize trimer formation enhanced humoral immunity without reducing the efficacy of the CTL response. This mutant, with deletions in the cleavage site, fusogenic domain, and spacing of heptad repeats 1 and 2, retained native antigenic conformational determinants as defined by binding to known monoclonal antibodies or CD4, oligomer formation, and virus neutralization in vitro. Importantly, this modified Env, gp140 Delta CFI, stimulated the antibody response to native gp160 while it retained its ability to induce a CTL response, a desirable feature for an AIDS vaccine.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Virol

DOI

ISSN

0022-538X

Publication Date

June 2002

Volume

76

Issue

11

Start / End Page

5357 / 5368

Location

United States

Related Subject Headings

  • env Gene Products, Human Immunodeficiency Virus
  • Virology
  • Vaccines, DNA
  • Vaccination
  • Mice, Inbred BALB C
  • Mice
  • Membrane Glycoproteins
  • Humans
  • HIV-1
  • HIV Envelope Protein gp160
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chakrabarti, B. K., Kong, W.-P., Wu, B.-Y., Yang, Z.-Y., Friborg, J., Ling, X., … Nabel, G. J. (2002). Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization. J Virol, 76(11), 5357–5368. https://doi.org/10.1128/jvi.76.11.5357-5368.2002
Chakrabarti, Bimal K., Wing-pui Kong, Bei-yue Wu, Zhi-Yong Yang, Jacques Friborg, Xu Ling, Steven R. King, David C. Montefiori, and Gary J. Nabel. “Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization.J Virol 76, no. 11 (June 2002): 5357–68. https://doi.org/10.1128/jvi.76.11.5357-5368.2002.
Chakrabarti BK, Kong W-P, Wu B-Y, Yang Z-Y, Friborg J, Ling X, et al. Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization. J Virol. 2002 Jun;76(11):5357–68.
Chakrabarti, Bimal K., et al. “Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization.J Virol, vol. 76, no. 11, June 2002, pp. 5357–68. Pubmed, doi:10.1128/jvi.76.11.5357-5368.2002.
Chakrabarti BK, Kong W-P, Wu B-Y, Yang Z-Y, Friborg J, Ling X, King SR, Montefiori DC, Nabel GJ. Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization. J Virol. 2002 Jun;76(11):5357–5368.

Published In

J Virol

DOI

ISSN

0022-538X

Publication Date

June 2002

Volume

76

Issue

11

Start / End Page

5357 / 5368

Location

United States

Related Subject Headings

  • env Gene Products, Human Immunodeficiency Virus
  • Virology
  • Vaccines, DNA
  • Vaccination
  • Mice, Inbred BALB C
  • Mice
  • Membrane Glycoproteins
  • Humans
  • HIV-1
  • HIV Envelope Protein gp160